SRY-box transcription factor 7 functions as a tumor suppressor regulating Wnt signaling and cancer stemness with its promoter methylation as a potential biomarker

BACKGROUND: Wnt signaling, critical for development, is often dysregulated in cancer via genetic or/and epigenetic changes. SOX7, a high mobility group protein, is downregulated in cancers, but its alterations and underlying mechanism in gastric cancer (GsCa) pathogenesis remain to be clearly defined. METHODS: SOX7 mRNA expression and promoter methylation were analyzed in GsCa. Functional impacts were assessed through assays for colony formation, proliferation (CCK-8), cell cycle/apoptosis (flow cytometry), migration/invasion (wound healing, Transwell), and ferroptosis. Mechanistic studies involving Western blot, immunofluorescence, dual-luciferase reporter assays, chromatin immunoprecipitation (ChIP)-qPCR, and bidirectional rescue experiments focused on the Wnt/β-catenin signaling and cancer stemness markers. RESULTS: SOX7 was widely expressed in normal tissues, including stomach, but was frequently downregulated in GsCa due to promoter CpG methylation, which correlated with worse overall patient survival. Functionally, SOX7 restoration inhibited GsCa cell growth by inducing G0/G1 arrest, ferroptosis, and apoptosis. It also suppressed migration and invasion by inhibiting epithelial-mesenchymal transition (EMT) and cancer stemness. Mechanistically, SOX7 is localized to nuclear speckles and antagonized Wnt/β-catenin signaling through sequestering active β-catenin in the cytoplasm, directly binding to Wnt target gene promoters (e.g., c-MYC), and competitively β-catenin displacement. Bidirectional rescue experiments confirmed its tumor-suppressive functions dependent on inactivation of β-catenin. CONCLUSIONS: SOX7 is a tumor suppressor in GsCa frequently inactivated by promoter methylation. It suppresses tumorigenesis by direct antagonizing Wnt signaling, thereby inhibiting EMT and stemness. SOX7 promoter methylation is a potential biomarker for GsCa prognosis and detection.

Authors

Institutions

Publication Details

Journal
Cellular Signalling
Published
2026-04-21
DOI
https://doi.org/10.1016/j.cellsig.2026.112556
Primary Topic
Wnt/β-catenin signaling in development and cancer
Type
article
Field-Weighted Citation Impact
0.00

Funders

Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

SRY-box transcription factor 7 functions as a tumor suppressor regulating Wnt signaling and cancer stemness with its promoter methylation as a potential biomarker

Xiaoxue Chai, Jianlian Xie, Bing Luo, Lili Li et al.
Cellular Signalling
Wnt/β-catenin signaling in development and cancer
article

SRY-box transcription factor 7 functions as a tumor suppressor regulating Wnt signaling and cancer stemness with its promoter methylation as a potential biomarker

Xiaoxue Chai, Jianlian Xie, Bing Luo, Lili Li, Qian Tao, Jun Zhou, Lihua Xie, Xi Zeng
article en

Abstract

BACKGROUND: Wnt signaling, critical for development, is often dysregulated in cancer via genetic or/and epigenetic changes. SOX7, a high mobility group protein, is downregulated in cancers, but its alterations and underlying mechanism in gastric cancer (GsCa) pathogenesis remain to be clearly defined. METHODS: SOX7 mRNA expression and promoter methylation were analyzed in GsCa. Functional impacts were assessed through assays for colony formation, proliferation (CCK-8), cell cycle/apoptosis (flow cytometry), migration/invasion (wound healing, Transwell), and ferroptosis. Mechanistic studies involving Western blot, immunofluorescence, dual-luciferase reporter assays, chromatin immunoprecipitation (ChIP)-qPCR, and bidirectional rescue experiments focused on the Wnt/β-catenin signaling and cancer stemness markers. RESULTS: SOX7 was widely expressed in normal tissues, including stomach, but was frequently downregulated in GsCa due to promoter CpG methylation, which correlated with worse overall patient survival. Functionally, SOX7 restoration inhibited GsCa cell growth by inducing G0/G1 arrest, ferroptosis, and apoptosis. It also suppressed migration and invasion by inhibiting epithelial-mesenchymal transition (EMT) and cancer stemness. Mechanistically, SOX7 is localized to nuclear speckles and antagonized Wnt/β-catenin signaling through sequestering active β-catenin in the cytoplasm, directly binding to Wnt target gene promoters (e.g., c-MYC), and competitively β-catenin displacement. Bidirectional rescue experiments confirmed its tumor-suppressive functions dependent on inactivation of β-catenin. CONCLUSIONS: SOX7 is a tumor suppressor in GsCa frequently inactivated by promoter methylation. It suppresses tumorigenesis by direct antagonizing Wnt signaling, thereby inhibiting EMT and stemness. SOX7 promoter methylation is a potential biomarker for GsCa prognosis and detection.

Cellular SignallingVol. 144
Qingdao University (CN), Chinese University of Hong Kong (HK), Hainan Medical University (CN), University of South China (CN)
Research Grants Council, University Grants Committee
Good health and well-being
Openalex Percentile: Top 21%
Wnt/β-catenin signaling in development and cancer
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.